Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 9, 2006, Pages 1614-1619

  Shen, Jing ^a   Desai, Manisha ^a   Agrawal, Meenakshi ^a   Kennedy, David O ^a   Senie, Ruby T ^a   Santella, Regina M ^a   Terry, Mary Beth ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1;

ACCURACY; ADULT; ARTICLE; BLOOD DONOR; BREAST CANCER; CANCER SCREENING; CIGARETTE SMOKING; CONTROLLED STUDY; DNA REPAIR; EXCISION REPAIR; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MARKER GENE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; SISTER GROUP; XERODERMA PIGMENTOSUM; XPA GENE; XPC GENE; XPD GENE; XPG GENE;

ADULT; BREAST NEOPLASMS; DNA REPAIR; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; ROC CURVE; SIBLINGS;

EID: 33749365627     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0218     Document Type: Article

References (42)

1. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000;92:874-97 .
2. Neumann AS, Sturgis EM, Wei Q. Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol Carcinog 2005;42:65-92.
3. Kennedy DO, Agarwal M, Shen J, et al. DNA repair capacity via removal of BPDE-DNA adducts in lymphoblastoid cell lines from sisters discordant for breast cancer. J Natl Cancer Inst 2005;97:127-32.
4. Ramos JM, Ruiz A, Colen R, et al. DNA repair and breast carcinoma susceptibility in women. Cancer 2004;100:1352-7.
5. Shi Q, Wang LE, Bondy ML, et al. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 2004;25:1695-700.
6. Grossman L, Matanoski G, Farmer E, et al. DNA repair as a susceptibility factor in chronic diseases in human populations. In: Dizdaroglu M, Karakaya E, editors. Advances in DNA damage and repair. New York: Kluwer Academic/Plenum Publishers; 1999. p. 149-67.
7. Lockett KL, Snowhite IV, Hu JJ. Nucleotide-exdsion repair and prostate cancer risk. Cancer Lett 2005;220:125-35.
8. Mayer C, Popanda O, Zelezny O, et al. DNA repair capacity after γ-irradiation and expression profiles of DNA repair genes in resting and proliferating human peripheral blood lymphocytes. DNA Repair (Amst) 2002;1:237-50.
9. Qiao Y, Spitz MR, Shen H, et al. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis 2002;23:295-9.
10. Vodicka P, Kumar R, Stetina R, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations, and single-strand breaks in DNA. Carcinogenesis 2004;25:757-63.
11. Wang Y, Spitz MR, Zhu Y, et al. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2003;2:901-8.
12. Wu X, Zhao H, Wei Q, et al. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis 2003:24:505-9.
13. Chen S, Tang D, Xue K, et al. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 2002;23:1321-5.
14. Hou SM, Falt S, Angelini S, et al. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 2002;23:599-503.
15. Sturgis EM, Castillo EJ, Li L, et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999;20:2125-9.
16. Winsey SL, Haldar NA, Marsh HP, et al. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 2000;60:5612-6.
17. Divine KK, Gilliland FD, Crowell RE, et al. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat Res 2001;461:273-8.
18. Kumar R, Hoglund L, Zhao C, et al. Single nucleotide polymorphisms in the XPG gene: determination of role in DNA repair and breast cancer risk. Int J Cancer 2003;103:671-5.
19. Collins A, Harrington V. Repair of oxidative DNA damage: assessing its contribution to cancer prevention. Mutagenesis 2002;17:489-93.
20. Spitz MR, Wu X, Wang Y, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001;61:1354-7.
21. Qiao Y, Spitz MR, Guo Z, et al. Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat Res 2002;509:165-74.
22. Lunn RM, Helzlsouer KJ, Parshad R, et al. XPD polymorphisms: effect on DNA repair proficiency. Carcinogenesis 2000;21:551-5.
23. John EM, Hopper JL, Beck JC, et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary, and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004;6:R375-89.
24. Ahsan H, Chen Y, Whittemore AS, et al. A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk. Breast Cancer Res Treat 2004;85:121-31.
25. Hosmer DW, Lemenshow S. Applied logistic regression. New York: John Wiley and Sons; 1989.
26. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
27. Leng S, Cheng J, Pan Z, et al. Associations between XRCC1 and ERCC2 polymorphisms and DNA damage in peripheral blood lymphocyte among coke oven workers. Biomarkers 2004;9:395-406.
28. Lee GY, Jang JS, Lee SY, et al. XPC polymorphisms and lung cancer risk. Int J Cancer 2005;115:807-13.
29. Blankenburg S, Konig IR, Moessner R, et al. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. Carcinogenesis 2005;26:1085-90.
30. Terry MB, Gammon MD, Zhang FF, et al. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2004;13:2053-8.
31. Takahashi Y, Moriwaki S, Sugiyama Y, et al. Decreased gene expression responsible for post-ultraviolet DNA repair synthesis in aging: a possible mechanism of age-related reduction in DNA repair capacity. J Invest Dermatol 2005;124:435-42.
32. de Boer J, Hoeijmakeers JHJ. Nucleotide excision repair and human syndromes. Carcinogenesis 2000;21:453-60.
33. Goukassian D, Gad F, Yaar M, et al. Mechanisms and implications of the age-associated decrease in DNA repair capacity. FASEB J 2000;14:1325-34.
34. Grossman L. Epidemiology of ultraviolet-DNA repair capacity and human cancer. Environ Health Perspect 1997;105 Suppl 4:927-30.
35. Moriwaki S, Ray S, Tarone RE, et al. The effect of donor age on the processing of UV-damaged DNA by cultured human cells: reduced DNA repair capacity and increased DNA mutability. Mutat Res 1996;364:117-23.
36. Wei Q, Matanoski GM, Farmer ER, et al. DNA repair capacity for ultraviolet light-induced damage is reduced in peripheral lymphocytes from patients with basal cell carcinoma. J Invest Dermatol 1995;104:933-6.
37. Alapetite C, Thirion P, de la RA, et al. Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients. Int J Cancer 1999;83:83-90.
38. Plappert UG, Stocker B, Fender H, et al. Changes in the repair capacity of blood cells as a biomarker for chronic low-dose exposure to ionizing radiation. Environ Mol Mutagen 1997;30:153-60.
39. Roth M, Rogers S, Roberts SS, et al. Stimulation of UV-induced DNA excision repair by chemotherapeutic drugs in cancer patients. Anticancer Res 1994;14:809-15.
40. D'Errico M, Calcagnile A, lavarone I, et al. Factors that influence the DNA repair capacity of normal and skin cancer-affected individuals. Cancer Epidemiol Biomarkers Prev 1999;8:553-9.
41. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003;361:598-604.
42. Moller P, Loft S. Interventions with antioxidants and nutrients in relation to oxidative DNA damage and repair. Mutat Res 2004;551:79-89.